- Home
- CEE vs HYPR Comparison
CEE vs HYPR Comparison
Compare CEE & HYPR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CEE
- HYPR
- Stock Information
- Founded
- CEE 1990
- HYPR 2014
- Country
- CEE Germany
- HYPR United States
- Employees
- CEE N/A
- HYPR N/A
- Industry
- CEE Finance Companies
- HYPR Medical Specialities
- Sector
- CEE Finance
- HYPR Health Care
- Exchange
- CEE Nasdaq
- HYPR Nasdaq
- Market Cap
- CEE 105.5M
- HYPR 113.9M
- IPO Year
- CEE N/A
- HYPR N/A
- Fundamental
- Price
- CEE $15.10
- HYPR $1.81
- Analyst Decision
- CEE
- HYPR Strong Buy
- Analyst Count
- CEE 0
- HYPR 3
- Target Price
- CEE N/A
- HYPR $1.28
- AVG Volume (30 Days)
- CEE 22.0K
- HYPR 427.1K
- Earning Date
- CEE 01-01-0001
- HYPR 11-11-2025
- Dividend Yield
- CEE 3.86%
- HYPR N/A
- EPS Growth
- CEE N/A
- HYPR N/A
- EPS
- CEE N/A
- HYPR N/A
- Revenue
- CEE N/A
- HYPR $10,797,000.00
- Revenue This Year
- CEE N/A
- HYPR $12.92
- Revenue Next Year
- CEE N/A
- HYPR $32.10
- P/E Ratio
- CEE N/A
- HYPR N/A
- Revenue Growth
- CEE N/A
- HYPR N/A
- 52 Week Low
- CEE $7.80
- HYPR $0.53
- 52 Week High
- CEE $10.32
- HYPR $2.19
- Technical
- Relative Strength Index (RSI)
- CEE 37.64
- HYPR 62.58
- Support Level
- CEE $14.76
- HYPR $1.40
- Resistance Level
- CEE $15.88
- HYPR $2.19
- Average True Range (ATR)
- CEE 0.42
- HYPR 0.15
- MACD
- CEE -0.02
- HYPR 0.04
- Stochastic Oscillator
- CEE 28.50
- HYPR 50.63
About CEE The Central and Eastern Europe Fund Inc. (The)
CENTRAL & EASTERN EUROPE FUND, INC. is a closed-end management investment company. The Fund's objective is to seek long-term capital appreciation. It invests in the equity or equity-linked securities of issuers domiciled in Central and Eastern Europe.
About HYPR Hyperfine Inc.
Hyperfine Inc is a medical device company that created Swoop. The Swoop Portable MR Imaging System produces high-quality images at a lower magnetic field strength than conventional MRI scanners. The company derives its revenue from sale of sales of MRI devices and service sales which consist of sales from subscriptions of bundled devices, maintenance, and software.